| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.3B | $19.8B | $17.7B | $16.0B | $14.1B | $12.5B | $16.6B | $15.7B |
| Cost of Revenue | — | — | — | — | — | $8.7B | $11.5B | $10.8B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B | — |
| SG&A Expense | $3.7B | $3.6B | $3.0B | $2.5B | $2.4B | $2.3B | $3.1B | $2.9B |
| Operating Income | $4.0B | $3.5B | $2.9B | $2.4B | $2.0B | $1.5B | $2.0B | $1.9B |
| Net Income | $2.9B | $2.6B | $2.0B | $1.8B | $1.4B | $0.9B | $1.4B | $1.3B |
| EPS (Basic) | $13.09 | $11.35 | $8.85 | $7.55 | $5.96 | $3.56 | $5.84 | $5.41 |
| EPS (Diluted) | $12.98 | $11.24 | $8.77 | $7.48 | $5.87 | $3.52 | $5.77 | $5.35 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.4B | $20.1B | $19.4B | $18.1B | $18.1B | $18.2B | $20.5B | $17.9B |
| Current Assets | $7.9B | $7.3B | $6.9B | $6.4B | $6.5B | $6.9B | $6.2B | $5.7B |
| Cash & Equivalents | $1.8B | $1.6B | $1.1B | $1.2B | $2.2B | $3.3B | $1.3B | $0.9B |
| Total Liabilities | $12.8B | $12.7B | $12.4B | $12.0B | $11.8B | $11.7B | $13.2B | $10.9B |
| Current Liabilities | $6.3B | $6.1B | $6.1B | $5.7B | $4.8B | $4.3B | $4.9B | $4.3B |
| Stockholders' Equity | $8.6B | $7.5B | $7.0B | $6.1B | $6.3B | $6.4B | $7.3B | $7.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.2B | $3.1B | $2.4B | $1.5B | $1.6B | $1.4B | $1.9B | $1.4B |
| Investing Cash Flow | $-0.6B | $-0.6B | $-1.2B | $-0.5B | $-0.5B | $-0.4B | $-1.8B | $-0.6B |
| Capital Expenditures | — | $0.4B | $0.3B | $0.3B | $0.2B | $0.1B | $0.3B | $0.4B |
| Financing Cash Flow | $-2.5B | $-2.0B | $-1.4B | $-1.9B | $-2.1B | $0.9B | $0.3B | $-1.4B |